DE69332377D1 - Verfahren zur modifizierung rekombinanter polypeptide - Google Patents
Verfahren zur modifizierung rekombinanter polypeptideInfo
- Publication number
- DE69332377D1 DE69332377D1 DE69332377T DE69332377T DE69332377D1 DE 69332377 D1 DE69332377 D1 DE 69332377D1 DE 69332377 T DE69332377 T DE 69332377T DE 69332377 T DE69332377 T DE 69332377T DE 69332377 D1 DE69332377 D1 DE 69332377D1
- Authority
- DE
- Germany
- Prior art keywords
- group
- alpha
- polypeptide
- terminal
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 229920001184 polypeptide Polymers 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 125000006239 protecting group Chemical group 0.000 abstract 4
- 238000003776 cleavage reaction Methods 0.000 abstract 3
- 230000007017 scission Effects 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 210000004899 c-terminal region Anatomy 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/003—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by transforming the C-terminal amino acid to amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4716—Muscle proteins, e.g. myosin, actin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91279892A | 1992-07-13 | 1992-07-13 | |
PCT/US1993/006591 WO1994001451A2 (en) | 1992-07-13 | 1993-07-13 | Method for modification of recombinant polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69332377D1 true DE69332377D1 (de) | 2002-11-14 |
DE69332377T2 DE69332377T2 (de) | 2003-07-03 |
Family
ID=25432466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69332377T Expired - Fee Related DE69332377T2 (de) | 1992-07-13 | 1993-07-13 | Verfahren zur modifizierung rekombinanter polypeptide |
Country Status (10)
Country | Link |
---|---|
US (1) | US5635371A (de) |
EP (2) | EP1170300A1 (de) |
JP (1) | JPH07509128A (de) |
AT (1) | ATE225801T1 (de) |
AU (1) | AU673190B2 (de) |
CA (1) | CA2140002A1 (de) |
DE (1) | DE69332377T2 (de) |
DK (1) | DK0651761T3 (de) |
NZ (1) | NZ255041A (de) |
WO (1) | WO1994001451A2 (de) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2715404B1 (fr) * | 1994-01-25 | 1996-03-15 | Biocem | Aconitases végétales et acides nucléiques codant pour ces aconitases. |
US6693081B2 (en) * | 1995-09-26 | 2004-02-17 | Osteopharm Inc. | Bone stimulating factor |
DE19713393C2 (de) * | 1997-04-01 | 2002-12-05 | Apotech Res & Dev Ltd | Flip-Gen und Flip-Protein |
GB9708918D0 (en) * | 1997-05-01 | 1997-06-25 | Ppl Therapeutics Scotland Ltd | Methods |
US20030207402A1 (en) * | 1997-08-22 | 2003-11-06 | Erhard Kopetzki | Autocatalytically activatable zymogenic precursors of proteases and their use |
GB9720054D0 (en) * | 1997-09-19 | 1997-11-19 | Celltech Therapeutics Ltd | Biological products |
GB9818938D0 (en) * | 1998-08-28 | 1998-10-21 | Alpharma As | Bioactive peptides |
US8283315B2 (en) | 1998-08-28 | 2012-10-09 | Lytix Biopharma As | Inhibition of tumour growth |
US6461834B1 (en) | 1998-11-06 | 2002-10-08 | Bionebraska, Inc. | Clostripain catalyzed amidation of peptides |
US6794159B1 (en) * | 1999-04-30 | 2004-09-21 | Pharmacia Corporation | Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
US6743600B1 (en) | 1999-04-30 | 2004-06-01 | Monsanto Technologies Llc | Method of removing N-terminal alanine residues from polypeptides with Aeromonas aminopeptidase |
KR100645843B1 (ko) | 2000-12-20 | 2006-11-14 | 에프. 호프만-라 로슈 아게 | 에리트로포이에틴 접합체 |
AU2002314111A1 (en) | 2001-06-15 | 2003-01-02 | F. Hoffmann-La Roche Ag | Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments |
US20030219854A1 (en) * | 2002-03-21 | 2003-11-27 | Micrologix Biotech Inc. | Methods for producing modified anti-infective peptides |
CA2443365C (en) * | 2002-11-19 | 2010-01-12 | F. Hoffmann-La Roche Ag | Methods for the recombinant production of antifusogenic peptides |
EP1740601B1 (de) * | 2004-04-21 | 2012-12-05 | The University of Chicago | Myosin-leichte-kette-kinase inhibitoren und deren verwendung |
US20060204512A1 (en) | 2004-09-23 | 2006-09-14 | Vasgene Therapeutics, Inc. | Polypeptide compounds for inhibiting angiogenesis and tumor growth |
EP2119724A1 (de) * | 2005-05-03 | 2009-11-18 | Novetide Ltd. | Festphaseverfahren zur Herstellung von Goserelin |
DE102005046113A1 (de) * | 2005-09-27 | 2007-03-29 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen |
CA2644529C (en) | 2006-03-09 | 2014-05-06 | F. Hoffmann-La Roche Ag | Anti-drug antibody assay |
EP2727936B1 (de) | 2006-11-22 | 2016-09-07 | Bristol-Myers Squibb Company | Gezielte Therapeutik auf Grundlage manipulierter Proteine für Tyrosinkinaserezeptoren, einschließlich IGF-IR |
CA2939778C (en) | 2007-01-31 | 2019-01-29 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
US20100144599A1 (en) | 2007-02-02 | 2010-06-10 | Bristol-Myers Squibb Company | Vegf pathway blockade |
KR101525754B1 (ko) | 2007-03-28 | 2015-06-09 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스티칭된 폴리펩티드 |
CL2008002053A1 (es) | 2007-07-17 | 2009-05-22 | Hoffmann La Roche | Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion. |
CL2008002054A1 (es) | 2007-07-17 | 2009-05-29 | Hoffmann La Roche | Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico. |
AR071874A1 (es) | 2008-05-22 | 2010-07-21 | Bristol Myers Squibb Co | Proteinas de dominio de armazon basadas en fibronectina multivalentes |
US20120172299A1 (en) | 2008-09-23 | 2012-07-05 | F. Hoffmann-La Roche Ag | Purification of erythropoietin |
TWI496582B (zh) | 2008-11-24 | 2015-08-21 | 必治妥美雅史谷比公司 | 雙重專一性之egfr/igfir結合分子 |
US8614297B2 (en) | 2008-12-22 | 2013-12-24 | Hoffmann-La Roche Inc. | Anti-idiotype antibody against an antibody against the amyloid β peptide |
JP5749744B2 (ja) | 2010-02-11 | 2015-07-15 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Igf−iポリ(エチレングリコール)コンジュゲート |
US9562089B2 (en) | 2010-05-26 | 2017-02-07 | Bristol-Myers Squibb Company | Fibronectin based scaffold proteins having improved stability |
SI2603600T1 (sl) | 2010-08-13 | 2019-04-30 | Aileron Therapeutics, Inc. | Peptidomimetični makrocikli |
JP5735650B2 (ja) | 2010-09-14 | 2015-06-17 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Peg化エリスロポエチンを精製するための方法 |
US20140187488A1 (en) | 2011-05-17 | 2014-07-03 | Bristol-Myers Squibb Company | Methods for maintaining pegylation of polypeptides |
KR20140100937A (ko) | 2011-10-18 | 2014-08-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
JP2015504038A (ja) | 2011-10-31 | 2015-02-05 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 低減した免疫原性を有するフィブロネクチン結合ドメイン |
MX349003B (es) | 2011-12-19 | 2017-07-06 | Hoffmann La Roche | Metodo para la deteccion del asociado de union libre de un aglutinante multiespecifico. |
JP2015507193A (ja) | 2012-02-01 | 2015-03-05 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 多重特異性結合物の結合パートナーを検出するための方法 |
CN104159595A (zh) | 2012-02-15 | 2014-11-19 | 爱勒让治疗公司 | 拟肽大环化合物 |
WO2013123267A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
CA2868883C (en) | 2012-03-30 | 2022-10-04 | Sorrento Therapeutics Inc. | Fully human antibodies that bind to vegfr2 |
ES2755104T3 (es) | 2012-05-17 | 2020-04-21 | Ra Pharmaceuticals Inc | Inhibidores peptídicos y peptidomiméticos |
WO2013177187A2 (en) | 2012-05-22 | 2013-11-28 | Massachusetts Institute Of Technology | Synergistic tumor treatment with extended-pk il-2 and therapeutic agents |
KR20220084444A (ko) | 2012-05-31 | 2022-06-21 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Pd-l1에 결합하는 항원 결합 단백질 |
US10377827B2 (en) | 2012-06-21 | 2019-08-13 | Sorrento Therapeutics, Inc. | Antigen binding proteins that bind c-met |
CN105051065A (zh) | 2012-06-22 | 2015-11-11 | 索伦托治疗有限公司 | 与ccr2结合的抗原结合蛋白 |
WO2014009474A1 (en) | 2012-07-13 | 2014-01-16 | F. Hoffmann-La Roche Ag | Method for the detection of a multispecific binder |
BR112015009470A2 (pt) | 2012-11-01 | 2019-12-17 | Aileron Therapeutics Inc | aminoácidos dissubstituídos e seus métodos de preparação e uso |
WO2014120891A2 (en) | 2013-02-01 | 2014-08-07 | Bristol-Myers Squibb Company | Fibronectin based scaffold proteins |
CA3133162C (en) | 2014-08-12 | 2024-02-13 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2 and integrin-binding-fc-fusion protein |
WO2016025645A1 (en) | 2014-08-12 | 2016-02-18 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2, a therapeutic antibody, and an immune checkpoint blocker |
EP3485910A2 (de) | 2014-08-22 | 2019-05-22 | Sorrento Therapeutics, Inc. | Antigenbindende proteine zur bindung von cxcr3 |
KR20170058424A (ko) | 2014-09-24 | 2017-05-26 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방 거대고리 및 이의 용도 |
KR20170080590A (ko) | 2014-11-05 | 2017-07-10 | 에프. 호프만-라 로슈 아게 | 효과기 기능 억제된 인간 또는 인간화된 약물 항체에 대항하는 항-약물 항체의 확인 방법 |
AU2016235424A1 (en) | 2015-03-20 | 2017-10-05 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
WO2017066525A1 (en) * | 2015-10-14 | 2017-04-20 | The Johns Hopkins University | Protein bioconjugation method |
EP4015533A1 (de) | 2015-10-29 | 2022-06-22 | F. Hoffmann-La Roche AG | Antikörper gegen variante fc-regionen und verfahren zur verwendung |
CA3013051A1 (en) | 2016-01-29 | 2017-08-03 | Heyue Zhou | Antigen binding proteins that bind pd-l1 |
EP3484911B1 (de) | 2016-07-15 | 2020-11-04 | H. Hoffnabb-La Roche Ag | Verfahren zur reinigung von pegyliertem erythropoetin |
US10350266B2 (en) | 2017-01-10 | 2019-07-16 | Nodus Therapeutics, Inc. | Method of treating cancer with a multiple integrin binding Fc fusion protein |
US10603358B2 (en) | 2017-01-10 | 2020-03-31 | Nodus Therapeutics | Combination tumor treatment with an integrin-binding-Fc fusion protein and immune stimulator |
WO2019036605A2 (en) | 2017-08-17 | 2019-02-21 | Massachusetts Institute Of Technology | MULTIPLE SPECIFICITY BINDING AGENTS OF CXC CHEMOKINES AND USES THEREOF |
HRP20220388T1 (hr) | 2017-12-29 | 2022-05-27 | F. Hoffmann - La Roche Ag | Postupak za dobivanje pegiliranog proteinskog pripravka |
CN111741770A (zh) | 2017-12-29 | 2020-10-02 | 豪夫迈·罗氏有限公司 | 用于提供聚乙二醇化蛋白质组合物的方法 |
ES2905105T3 (es) | 2017-12-29 | 2022-04-07 | Hoffmann La Roche | Procedimiento para proporcionar una composición de proteína PEGilada |
WO2020154032A1 (en) | 2019-01-23 | 2020-07-30 | Massachusetts Institute Of Technology | Combination immunotherapy dosing regimen for immune checkpoint blockade |
WO2022065052A1 (ja) * | 2020-09-24 | 2022-03-31 | 株式会社Jvcケンウッド | 捕捉用抗体、固相担体、検出用抗体、固相担体粒子、並びに検出対象物質の測定キット及び測定方法 |
CN117858905A (zh) | 2021-08-19 | 2024-04-09 | 豪夫迈·罗氏有限公司 | 多价抗变体fc区抗体及使用方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4431739A (en) * | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
JP2624470B2 (ja) * | 1984-10-02 | 1997-06-25 | バイオジェン インコーポレイテッド | ストレプトアビジン様ポリペプチドの製造 |
US5166321A (en) * | 1985-01-28 | 1992-11-24 | International Genetic Engineering, Inc. | Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria |
JPS6229997A (ja) * | 1985-04-08 | 1987-02-07 | Sankyo Co Ltd | C末端にプロリンアミドを有するペプチドの製法 |
US4801536A (en) * | 1985-10-11 | 1989-01-31 | Genetics Institute, Inc. | Method for producing heterologous proteins |
US4743679A (en) * | 1986-02-24 | 1988-05-10 | Creative Biomolecules, Inc. | Process for producing human epidermal growth factor and analogs thereof |
ATE247708T1 (de) * | 1986-10-02 | 2003-09-15 | Massachusetts Inst Technology | Verfahren zur regulierung der metabolischen stabilität von proteinen |
US4810777A (en) * | 1987-03-04 | 1989-03-07 | The United States Of America As Represented By The Department Of Health And Human Services | Antimicrobial compounds |
AU605291B2 (en) * | 1987-03-20 | 1991-01-10 | Micromet Ag | Process for the purification of recombinant polypeptides |
AU601273B2 (en) * | 1987-03-20 | 1990-09-06 | Creative Biomolecules, Inc. | Leader sequences for the production of recombinant proteins |
DK0394194T3 (da) * | 1989-04-17 | 1994-01-10 | Calbiochem Novabiochem Ag | Beskyttede aminosyrer og fremgangsmåde til fremstilling deraf |
US5137872A (en) * | 1989-09-18 | 1992-08-11 | Pitman-Moore, Inc. | Growth hormone-releasing factor analogs |
US5101059A (en) * | 1989-12-05 | 1992-03-31 | Research Corporation Technologies, Inc. | Amino acid protecting groups |
US5045531A (en) * | 1989-12-18 | 1991-09-03 | Magainin Sciences Inc. | Wound treatment employing biologically active ion channel forming peptides and proteins |
JPH0423995A (ja) * | 1990-05-21 | 1992-01-28 | Takara Shuzo Co Ltd | トランスペプチデーション用試薬及び方法 |
US5169935A (en) * | 1990-06-20 | 1992-12-08 | The Salk Institute For Biological Studies | Method of making peptides |
GB9015369D0 (en) * | 1990-07-12 | 1990-08-29 | Erba Carlo Spa | Amidated fibrinolytic enzymes and their precursors,and processes for their preparation |
ZA922746B (en) * | 1991-04-26 | 1992-12-30 | Lilly Co Eli | Superactive grf analogs |
FR2687680A1 (fr) * | 1992-02-20 | 1993-08-27 | Centre Nat Rech Scient | Procede de marquage de proteines et de peptides par acylation de leur fonction alpha aminee par un reactif comportant une fonction carboxylique activee. |
-
1993
- 1993-07-13 AT AT93918187T patent/ATE225801T1/de not_active IP Right Cessation
- 1993-07-13 DE DE69332377T patent/DE69332377T2/de not_active Expired - Fee Related
- 1993-07-13 CA CA002140002A patent/CA2140002A1/en not_active Abandoned
- 1993-07-13 DK DK93918187T patent/DK0651761T3/da active
- 1993-07-13 JP JP6503577A patent/JPH07509128A/ja not_active Ceased
- 1993-07-13 WO PCT/US1993/006591 patent/WO1994001451A2/en active IP Right Grant
- 1993-07-13 EP EP01103311A patent/EP1170300A1/de not_active Withdrawn
- 1993-07-13 EP EP93918187A patent/EP0651761B1/de not_active Expired - Lifetime
- 1993-07-13 AU AU47725/93A patent/AU673190B2/en not_active Ceased
- 1993-07-13 NZ NZ255041A patent/NZ255041A/en unknown
-
1994
- 1994-08-23 US US08/294,434 patent/US5635371A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1994001451A2 (en) | 1994-01-20 |
DK0651761T3 (da) | 2003-02-10 |
CA2140002A1 (en) | 1994-01-20 |
US5635371A (en) | 1997-06-03 |
EP0651761B1 (de) | 2002-10-09 |
WO1994001451A3 (en) | 1994-03-03 |
AU673190B2 (en) | 1996-10-31 |
AU4772593A (en) | 1994-01-31 |
EP1170300A1 (de) | 2002-01-09 |
ATE225801T1 (de) | 2002-10-15 |
JPH07509128A (ja) | 1995-10-12 |
NZ255041A (en) | 1996-11-26 |
EP0651761A1 (de) | 1995-05-10 |
DE69332377T2 (de) | 2003-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE225801T1 (de) | Verfahren zur modifizierung rekombinanter polypeptide | |
DE69817211D1 (de) | Charakterisierung von polypeptiden | |
KR970702917A (ko) | Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체 | |
Balian et al. | Structure of rat skin collagen α1-CB8. Amino acid sequence of the hydroxylamine-produced fragment HA1 | |
DE60042617D1 (de) | Verfahren zur therapeutischen Verwendung von löslichen rezeptoren BR43X2 | |
WO1995003405A3 (en) | Enzymatic method for modification of recombinant polypeptides | |
NZ232742A (en) | Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced | |
WO1994018332A3 (en) | Anthrax toxin fusion proteins and uses thereof | |
UA40625C2 (uk) | Конструкція днк, рекомбінантний експресуючий вектор, спосіб одержання гетерологічного поліпептиду | |
IL96043A0 (en) | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known | |
ATE229068T1 (de) | Verfahren zur produktion von polypeptiden | |
IL90832A0 (en) | Gene leader fragment encoding a peptide leader sequence and a polypeptide sequence | |
ATE253639T1 (de) | Verfahren zur herstellung von peptiden | |
DE69940927D1 (de) | PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT | |
EP0339217A3 (en) | Specific peptide bond cleavage by organic tertiary phosphines with nucleophilic side chains | |
EP0846950A3 (de) | Peptide brauchbar als Mikrosequenzierungsstandard und Verfahren zu derer Anwendung | |
DE69019077T2 (de) | Verfahren zur herstellung von c-terminalen alpha-amidierten peptiden. | |
ES2079054T3 (es) | Peptidilhidroxiglicina n-c-liasa y adn codificante de la misma. | |
WO1999002708A8 (en) | Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein | |
ATE139572T1 (de) | Verfahren zur reinigung von rekombinanten proteinen und dafür nützliche produkte | |
ATE139538T1 (de) | Verfahren zur selektiven spaltung von fusionsproteinen | |
Facchetti et al. | RP-HPLC peptide mapping methods for the analysis of recombinant human pro-urokinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |